Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 45

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 45
---

Each Enfusion restricted stock unit that vests in whole or in part based on performance-based vesting conditions (an “”) that is outstanding as of immediately prior to the Effective Time and vests as a result of the consummation of the Transactions will be cancelled and converted at the Effective Time into the right of the holder to receive the Per
Share Mixed Consideration in respect of each share of Enfusion Common Stock subject to such vested Enfusion PSU (with the applicable performance conditions deemed achieved or not achieved based on the terms of the applicable award agreement), less
applicable tax withholding. Each Enfusion PSU that does not vest at the Effective Time will be cancelled as of the Effective Time for no consideration.

Treatment of Employee Stock Purchase Plan

As soon as reasonably practicable after the date of the Merger Agreement, Enfusion will take all actions necessary or required under the
Enfusion, Inc. 2021 Stock Purchase Plan (the “”) to provide that (a) no new offering or purchase period under the Enfusion ESPP will commence after the date of the Merger Agreement, (b) no new participants
will be permitted into the Enfusion ESPP after the date of the Merger

23

Agreement, (c) the existing participants in the Enfusion ESPP may not increase their elections with respect to the offering or purchase periods in effect on the date of the Merger Agreement,
(d) the exercise date for any offering or purchase period in effect as of the date of the Merger Agreement will be the earlier of the original exercise date for such offering and the date that is 60 days after the date of the Merger Agreement
(the “”), (e) each participant’s accumulated contributions under the Enfusion ESPP will be used to purchase shares of Enfusion Common Stock in accordance with the terms of the Enfusion ESPP as of the Final
Exercise Date, and (f) the Enfusion ESPP will terminate on the date immediately prior to the date on which the Effective Time occurs.

Listing of Clearwater Common Stock; Delisting of Enfusion Common Stock(see page 114)

It is a condition to the completion of
the Transactions that the shares of Clearwater Common Stock to be issued to Enfusion Stockholders in the Transactions be approved for listing on New York Stock Exchange, subject to official notice of issuance. As a result of the Transactions, shares
of Enfusion Common Stock will cease to be listed on the New York Stock Exchange.

Appraisal Rights of Enfusion Stockholders (see